Eli Lilly and Company LLY
NYSE · United States · Health Technology
$1,157.08-27.55 (-2.33%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Johnson & Johnson shares climbed despite slower revenue growth, as investors weigh new-drug momentum against Stelara losses and softer MedTech sales.
The Danish drugmaker promised new blockbuster medicines and expanded pill capacity, but investors wanted a clearer measure of growth before patents expire.
The agreement connects Twist’s lab services with Lilly’s AI models, but neither company disclosed financial terms or projected revenue.